C Protzel1, A Führer2, O W Hakenberg3. 1. Urologische Klinik und Poliklinik, Universitätsmedizin Rostock, Ernst-Heydemann-Straße 6, 18055, Rostock, Deutschland. 2. Sektion Nephrologie, Medizinische Klinik II, Universitätsmedizin Rostock, Rostock, Deutschland. 3. Urologische Klinik und Poliklinik, Universitätsmedizin Rostock, Ernst-Heydemann-Straße 6, 18055, Rostock, Deutschland. oliver.hakenberg@med.uni-rostock.de.
Abstract
BACKGROUND: Terminal renal insufficiency is characterized by the need for renal replacement therapy for survival of the patient. In addition to several types of dialysis treatment, successful renal transplantation offers the best form of renal replacement therapy in terms of long-term patient survival and quality of life. METHOD: Living donor renal transplantation offers the best conditions concerning quality of organ transplanted and graft survival. CONCLUSION: The risk of complications associated with renal transplantation are manageable; however, these must be weighed against the potential benefits of successful transplantation.
BACKGROUND: Terminal renal insufficiency is characterized by the need for renal replacement therapy for survival of the patient. In addition to several types of dialysis treatment, successful renal transplantation offers the best form of renal replacement therapy in terms of long-term patient survival and quality of life. METHOD: Living donor renal transplantation offers the best conditions concerning quality of organ transplanted and graft survival. CONCLUSION: The risk of complications associated with renal transplantation are manageable; however, these must be weighed against the potential benefits of successful transplantation.
Entities:
Keywords:
Living kidney donor; Organ donors; Renal dialysis; Renal insufficiency, chronic; Renal replacement therapy
Authors: Rachael L Morton; Paul Snelling; Angela C Webster; John Rose; Rosemary Masterson; David W Johnson; Kirsten Howard Journal: CMAJ Date: 2012-02-06 Impact factor: 8.262
Authors: Daniel Abramowicz; Pierre Cochat; Frans H J Claas; Uwe Heemann; Julio Pascual; C Dudley; Paul Harden; Marivonne Hourmant; Umberto Maggiore; Maurizio Salvadori; Goce Spasovski; Jean-Paul Squifflet; Jürg Steiger; Armando Torres; Ondrej Viklicky; Martin Zeier; Raymond Vanholder; Wim Van Biesen; Evi Nagler Journal: Nephrol Dial Transplant Date: 2014-07-09 Impact factor: 5.992
Authors: Germaine Wong; Kirsten Howard; Jeremy R Chapman; Steven Chadban; Nicholas Cross; Allison Tong; Angela C Webster; Jonathan C Craig Journal: PLoS One Date: 2012-01-18 Impact factor: 3.240
Authors: Ming Yen Lin; Mei Chuan Kuo; Chi Chih Hung; Wen Jeng Wu; Li Tzong Chen; Ming Lung Yu; Chih-Cheng Hsu; Chien-Hung Lee; Hung-Chun Chen; Shang-Jyh Hwang Journal: PLoS One Date: 2015-04-13 Impact factor: 3.240